Détail de la revue
Documents disponibles dans cette revue
trié(s) par (Pertinence décroissant(e), Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) Mettre toutes les notices dans le panier Faire une suggestion Ajouter un critère de recherche
Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network
Solé G, Salort-Campana E, Pereon Y, et al.
Revue neurologique, 2020, 176, 6, p 507
Développement de nouveaux marqueurs chez les patients SMA type III et IV
Querin G, Lenglet T, Debs R, et al.
Revue neurologique, 2020
Thérapie génique (TG) dans l’amyotrophie spinale de type 1 (SMA1) : suivi à long terme (SLT) de l’essai clinique de phase 1 évaluant l’onasemnogène abeparvovec
Jerry RM, Shell R, Kelly JL, et al.
Revue neurologique, 2020
Associated pediatric neuromyelitis optica and dermatomyositis: A case report.
Khattab H, Rafai MA, El Moutawakil B, et al.
Revue neurologique, 2019
Life-threatening lactic acidosis occurring in adults with mitochondrial disorders
Brisset M, Behin A, Pottier C, et al.
Revue neurologique, 2019
Myasthenia gravis exacerbation after red yeast rice use
Dobremez V, Serra A, Grosset-Janin D, et al.
Revue neurologique, 2018, 174, 7-8, p 577
The first French case of MATR3-related distal myopathy: Clinical, radiological and histopathological characterization
Barp A, Malfatti E, Metay C, et al.
Revue neurologique, 2018
Encephalopathy associated with a reversible splenial lesion in riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency
Touat M, Touat M, Michaud M, et al.
Revue neurologique, 2018, 174, 10, p 747
Myopathy with MTCYB mutation mimicking Multiple Acyl-CoA Dehydrogenase Deficiency
Kaphan E, Kaphan E, Bou Ali H, et al.
Revue neurologique, 2018, 174, 10, p 731
Myasthenia gravis exacerbation after red yeast rice use
Dobremez V, Serra A, Grosset-Janin D, et al.
Revue neurologique, 2018, 174, 7-8, p 577
Motor neuron disease of very long disease duration or Charcot-Marie-Tooth disease? A novel phenotype related to the SOD1 p.E22G variant
Querin G, Corcia P, Lenglet T, et al.
Revue neurologique, 2017, 173, 10, p 671
Adult-onset spinal muscular atrophy: An update
Juntas Morales R, Pageot N, Taïeb G, et al.
Revue neurologique, 2017, 173, 5, p 308
Kennedy disease (X-linked recessive bulbospinal neuronopathy): A comprehensive review from pathophysiology to therapy
Querin G, Soraru G, Pradat PF
Revue neurologique, 2017, 173, 5, p 326
Motor neuropathies and lower motor neuron syndromes
Verschueren A
Revue neurologique, 2017, 173, 5, p 320
Cardiac arrhythmia and late-onset muscle weakness caused by a myofibrillar myopathy with unusual histopathological features due to a novel missense mutation in FLNC
Avila Smirnow D, Gueneau L, Batonnet-Pichon S, et al.
Revue neurologique, 2016, 172, 10, p 594
Exercise training in metabolic myopathies
Vissing J, Vissing J
Revue neurologique, 2016, 172, 10, p 559
Muscle MRI of facioscapulohumeral dystrophy (FSHD): A growing demand and a promising approach
Fatehi F, Salort-Campana E, Le Troter A, et al.
Revue neurologique, 2016, 172, 10, p 566
Nemaline myopathies: State of the art
Malfatti E, Romero NB
Revue neurologique, 2016, 172, 10, p 614
Sporadic inclusion-body myositis: Recent advances and the state of the art in 2016
Gallay L, Petiot P
Revue neurologique, 2016, 172, 10, p 581
Unravelling the myotonic dystrophy type 1 clinical spectrum: A systematic registry-based study with implications for disease classification
De Antonio M, Dogan C, Hamroun D, et al.
Revue neurologique, 2016, 172, 10, p 572
What have we learned about glycogenosis in recent years?
Laforêt P
Revue neurologique, 2016, 172, 10, p 541
